Want to double your money in 2026? This is what I'd buy

High-quality ASX tech stocks are now trading well below prior highs.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Finding stocks that can realistically double in a year is not easy. Most of the time, those kinds of returns come with higher risk or rely on a big change in sentiment.

Right now, that shift is starting to show up in parts of the ASX tech sector.

After a sharp sell-off through late 2025 and early 2026, several high-quality names have fallen well below previous highs. In some cases, the underlying business has kept improving while the share price moved the other way.

That gap is what stands out.

If I were looking for positions with strong re-rating potential from current levels, these are the three ASX stocks I would focus on.

A white and black clock face is shown with Time to Buy written.

Image source: Getty Images

WiseTech Global Ltd (ASX: WTC)

WiseTech is a clear example of sentiment disconnecting from business performance.

The company continues to expand its CargoWise platform globally, with revenue lifting strongly following the e2open acquisition. In its latest result, revenue rose 76% to $672 million, while EBITDA increased 31%.

At the same time, the share price has been under heavy pressure. The stock is still well below its 2025 highs after falling rapidly over the past year.

Some of that reflects margin compression tied to acquisitions and governance concerns. But those are not structural issues with the core platform.

CargoWise remains deeply embedded across global logistics networks. Once in place, it is difficult to replace, which supports recurring revenue and pricing power.

If sentiment stabilises, this is the type of stock that can move quickly.

Pro Medicus Ltd (ASX: PME)

Pro Medicus sits at the premium end of the ASX tech space, but the business model continues to justify that position.

The company delivers medical imaging software to major hospital networks, mainly in the United States. Its contracts are long-dated, high-margin, and often include minimum usage volumes.

That creates strong revenue visibility.

Recent results showed revenue up 28.4% and EBIT up 29.7%, with more than $1 billion in forward contracted revenue.

The key point here is consistency. Growth has remained strong even as the share price pulled back over the past year.

It is a high-quality operator that has been repriced with the sector.

Xero Ltd (ASX: XRO)

Xero offers a different angle, but the same setup.

The company continues to grow its global subscriber base, with users reaching 4.59 million in the latest half. Revenue increased 20% to $1.19 billion, with improving EBITDA margins.

At the same time, the share price has fallen heavily alongside the broader tech sell-off.

There are still execution risks, particularly around US expansion and competition. But the core model remains strong.

Xero generates recurring subscription revenue and continues to lift pricing through product improvements.

If growth holds and sentiment shifts, there is room for the multiple to expand again.

Foolish takeaway

All three of these companies have seen large drawdowns despite continuing to grow.

This is not about finding unknown ASX small-caps. These are established businesses that have already proven their models at scale.

The risk is that sentiment stays weak or growth slows.

But if the market continues rotating back into tech, these are the types of companies that are likely move the most.

Personally, I see this more as a sentiment reset than a change in fundamentals. That is why I would be looking here first.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Opinions

I'd buy this ASX share because it offers almost everything an investor could want

This business ticks a lot of boxes!

Read more »

A young man looks like he his thinking holding his hand to his chin and gazing off to the side amid a backdrop of hand drawn lightbulbs that are lit up on a chalkboard.
Opinions

Is the AGL share price a buy at $8.50 today?

AGL shares are down, but are they out?

Read more »

iPhone with the logo and the word Google spelt multiple times in the background.
Opinions

Here's why I'd add Alphabet shares to an ASX stock portfolio right now

Why not add this world-class company to your portfolio?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Opinions

Meet the $1 ASX stock that's obliterated Nvidia in the last 12 months

This impressive stock has more than doubled the performance of Nvidia.

Read more »

Legendary share market investing expert and owner of Berkshire Hathaway, Warren Buffett.
Opinions

3 ASX stocks that look like classic Warren Buffett investments

Here's why I think the Oracle of Omaha be interested in the ASX shares.

Read more »

Siblings laying upside down on a couch.
Opinions

2 ASX 200 shares I'd want my kids to own

These are two of my top picks right now.

Read more »

A boy stands firm on a rocky cliff holding a rocket in each hand and looking up toward the sky, anticipating flying into space.
ETFs

SpaceX IPO: Should you buy an ASX space ETF to cash in?

The countdown is on.

Read more »

A man in a suit looks sad as oil is spilled from a barrel.
Opinions

Could another oil shock tank the ASX stock market?

Once again, all eyes on on the Strait...

Read more »